Austria (AT)

A smartphone application to reduce problematic drinking: a feasibility trial (2024) Lukas C, Blechert J, Berking M Journal article Publisher Correction: Determinants of exposure to acrylamide in European children and adults based on urinary biomarkers: results from the “European Human Biomonitoring Initiative” HBM4EU participating studies (Scientific Reports, (2023), 13, 1, (21291), 10.1038/s41598-023-48738-6) (2024) F. Fernández S, Poteser M, Govarts E, Pardo O, Coscollà C, Schettgen T, Vogel N, et al. Journal article, Erratum Nuclear and mitochondrial genetic variants associated with mitochondrial DNA copy number (2024) Koller A, Filosi M, Weissensteiner H, Fazzini F, Gorski M, Pattaro C, Schönherr S, et al. Journal article METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII (2024) Kocak B, Akinci D’Antonoli T, Mercaldo N, Alberich-Bayarri A, Baessler B, Ambrosini I, Andreychenko AE, et al. Journal article High-Statistics Measurement of the Cosmic-Ray Electron Spectrum with H.E.S.S. (2024) Aharonian F, Benkhali FA, Aschersleben J, Ashkar H, Backes M, Martins VB, Batzofin R, et al. Journal article Differences between Current Clinical Practice and Evidence-Based Guideline Recommendations Regarding Tocolysis – an Austria-wide Survey (2024) Enengl S, Rath W, Kehl S, Oppelt P, Mayr A, Stroemer A, Eichinger T, et al. Journal article Von „Sachlich und sehr kompetent!! …Halt wie ein Arzt sein soll!!“ zu „Eine Frechheit! Nie wieder und nicht weiter zuempfehlen.“: Linguistische Einblicke in das kommunikative Handeln in Online-Arztbewertungen im deutsch-spanischen Sprachvergleich (2024) Mayr P, Mayr H Journal article Deciphering the transfer of hydroclimate signals to tree-ring δ18O using a proxy system model in East Asia's Meiyu region (2024) Zhao Y, Lu H, Fang K, Zhang P, Chen D, Bräuning A, Grießinger J, et al. Journal article SoK: Descriptive Statistics Under Local Differential Privacy (2024) Raab R, Berrang P, Gerhart P, Schröder D Journal article Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort (2024) de Castro T, Welland S, Jochheim L, Leyh C, Shmanko K, Finkelmeier F, Jeliazkova P, et al. Journal article